The problem arises as a result of deterioration of either physical health or mental. Men over 40 years of age have a high risk of developing erectile dysfunction, including those who take a large number of different medications. But here it should be noted that starting at about 50 years old, an erection naturally gradually decreases,…
The article will tell in detail about ways to increase male potency. The potencyis extremely important for men at any age. It affects not only the sexual life but also the functioning of many systems in the body: endocrine, urinary and sexual. Male potency problems can begin after the age of 40. Their severity depends…
The potency is an important component of the life of every man. There are several effective ways to increase potency with the help of foods. What foods can be used to boost male potency? Products that can influence male potency have long been called aphrodisiacs. The name “aphrodisiac” originated in Ancient Greece from the goddess…
The history of the use of cannabis for medicinal purposes has more than 4000 years. The first mention of it is contained in the ancient Indian sources, which described the psychoactive properties of cannabis and its use in the treatment and prevention of various diseases. In recent years, interest in cannabis as a drug has…
Shares of Matinas Biopharma Holdings Inc. (MTNB) have performed extremely well over the past few months, up a whopping 365% since September 1, 2016. That kind of impressive move is representative of why investors are attracted to small-cap biopharma stocks. The right call can make you a lot of money in just a short period…
Vitality Biopharma, Inc. (VBIO) is developing a new class of cannabinoid prodrugs, known as cannabosides, to overcome the limitations of raw Cannabis sativa or synthetic cannabinoids. It is a strategy I believe can create significant value due to the differentiation of cannaboside products from existing cannabinoids available through prescription or over-the-counter means. The strategy also effectively distinguishes Vitality…
BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is biopharmaceutical company developing adult stem cell-based therapies for a variety of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Parkinson’s disease (PD). The company’s NurOwn® technology is based on the use of mesenchymal stem cells (MSCs), engineered ex vivo, to express increased amount of neurotrophic factors (NTFs)….
I think VistaGen Therapeutics’ (VTGN) AV-101 is one of the more interesting small-cap biopharma assets in mid-stage development. I’ve written in the past that I think AV-101 has blockbuster sales potential. Heck, there was just a Reuters story out today talking about how large and open this market is. The drug is currently in a Phase 2a…
MabVax Therapeutics (MBVX) is another company I had a very opportunistic meeting with because they announced that morning the IND for MVT-1075 had been filed. If all goes smoothly, we should see MVT-1075 in the clinic in the second quarter 2017. Now we all know billions (if not trillions) of mice have been cured of cancer over…
As expected, much of my meeting with RedHill Biopharma (RDHL) was focused on the company’s newly acquired rights to Donnatal® in certain areas of the U.S. Now I’ve been traveling for the past several days, so I have not had an opportunity yet to do a deep dive into Donnatal but what I do know is that…